Capital One National Association’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,881
Closed -$217K 518
2017
Q4
$217K Sell
4,881
-310
-6% -$14.3K 0.01% 490
2017
Q3
$263K Buy
5,191
+478
+10% +$24.3K 0.02% 464
2017
Q2
$254K Sell
4,713
-49
-1% -$2.61K 0.02% 456
2017
Q1
$251K Sell
4,762
-5,642
-54% -$286K 0.02% 462
2016
Q4
$501K Buy
10,404
+12
+0.1% +$593 0.04% 331
2016
Q3
$561K Buy
10,392
+664
+7% +$36.4K 0.04% 299
2016
Q2
$527K Buy
+9,728
New +$512K 0.04% 304
2015
Q2
Sell
-4,432
Closed -$256K 549
2015
Q1
$256K Buy
+4,432
New +$254K 0.02% 481

Other funds holding GSK

Capital One National Association's GSK Position: Q1 2018 in Review

Capital One National Association sold out of GSK (GSK) in Q1 2018, closing a stake of 4,881 shares — an estimated $217K sold.

Capital One National Association first reported a position in GSK in Q1 2015 and held it in 8 quarters. The position peaked at $561K in Q3 2016. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • Capital One National Association reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • Capital One National Association sold 4,881 GSK shares in Q1 2018, an estimated $217K.
  • Capital One National Association first reported a position in GSK in Q1 2015 and held it in 8 quarters.
  • Capital One National Association's GSK position peaked at $561K in Q3 2016.
  • 778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Capital One National Association's 13F filing for Q1 2018, filed 23 Apr 2018.